ASPM and prostate cancer: ASPM is a positive regulator of the canonical Wnt/β-catenin signaling (Major et al., 2008; Hsu et al., 2019) and thus promotes cancer stemness and progression in prostate cancer (Pai et al., 2019) and hepatocellular carcinoma (Liao et al., 2020).